{"id":"ritlecitinib-20-mg","rwe":[],"tags":[],"safety":{"drugInteractions":[{"drug":"Warfarin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"P-glycoprotein inhibitors","action":"Avoid","effect":"Increased ritlecitinib plasma concentrations"},{"drug":"P-glycoprotein inducers","action":"Avoid","effect":"Decreased ritlecitinib plasma concentrations"},{"drug":"Strong CYP3A4 inhibitors","action":"Avoid","effect":"Increased ritlecitinib plasma concentrations"},{"drug":"Strong CYP3A4 inducers","action":"Avoid","effect":"Decreased ritlecitinib plasma concentrations"},{"drug":"CYP2C8 inhibitors","action":"Avoid","effect":"Increased ritlecitinib plasma concentrations"},{"drug":"CYP2C8 inducers","action":"Avoid","effect":"Decreased ritlecitinib plasma concentrations"},{"drug":"CYP2C19 inhibitors","action":"Avoid","effect":"Increased ritlecitinib plasma concentrations"},{"drug":"CYP2C19 inducers","action":"Avoid","effect":"Decreased ritlecitinib plasma concentrations"},{"drug":"CYP2D6 inhibitors","action":"Avoid","effect":"Increased ritlecitinib plasma concentrations"},{"drug":"CYP2D6 inducers","action":"Avoid","effect":"Decreased ritlecitinib plasma concentrations"},{"drug":"CYP3A4 substrates","action":"Monitor","effect":"Increased plasma concentrations of CYP3A4 substrates"},{"drug":"CYP2C8 substrates","action":"Monitor","effect":"Increased plasma concentrations of CYP2C8 substrates"},{"drug":"CYP2C19 substrates","action":"Monitor","effect":"Increased plasma concentrations of CYP2C19 substrates"},{"drug":"CYP2D6 substrates","action":"Monitor","effect":"Increased plasma concentrations of CYP2D6 substrates"},{"drug":"P-glycoprotein substrates","action":"Monitor","effect":"Increased plasma concentrations of P-glycoprotein substrates"}],"commonSideEffects":[],"contraindications":["If you’ve had an allergic reaction: If you’ve had an allergic reaction to Litfulo or any of its ingredients, your doctor likely won’t prescribe Litfulo for you. This is because taking the drug could cause another allergic reaction. You can ask your doctor about other treatments that may be better options for you.","rifampin (Rifadin)","carbamazepine(Tegretol)"],"specialPopulations":{"Pregnancy":"Use is contraindicated. Patients of childbearing potential should be advised to use effective contraception during therapy and for 1 month after the last dose; this drug is not recommended for those not using contraception. Animal studies have revealed evidence of fetotoxicity and teratogenicity. There are no controlled data in human pregnancy. To monitor the outcomes of pregnant women exposed to this drug, a pregnancy registry has been established.","Geriatric use":"text not available","Paediatric use":"text not available","Renal impairment":"text not available","Hepatic impairment":"text not available"}},"trials":[],"aliases":[],"company":"Pfizer","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=ritlecitinib-20-mg","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-19T23:56:40.371739+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-19T23:56:51.607602+00:00"},"regulatory.eu":{"url":"","method":"api_direct","source":"European Medicines Agency","rawText":"","confidence":1,"sourceType":"ema_api","retrievedAt":"2026-04-19T23:56:40.389398+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ritlecitinib-20-mg","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-19T23:56:52.346205+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: TEC family kinase inhibitor","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-19T23:56:53.314602+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL5314649/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-19T23:56:53.211903+00:00"}},"allNames":"ritlecitinib 20 mg","offLabel":[],"timeline":[],"brandName":"Ritlecitinib 20 mg","ecosystem":[],"isGeneric":true,"mechanism":{"target":"JAK3/STAT3 pathway","novelty":"best-in-class","modality":"small molecule","drugClass":"small molecule inhibitor","explanation":"","oneSentence":"","technicalDetail":"Ritlecitinib-20-mg is a small molecule inhibitor targeting the JAK3/STAT3 pathway, which plays a crucial role in the development of alopecia areata. By inhibiting this pathway, ritlecitinib-20-mg aims to promote hair growth and reduce inflammation. This mechanism of action has been shown to be effective in clinical trials."},"_companyIR":{"url":"https://www.pfizer.com/investors","revenueRefs":[],"pipelineRefs":[]},"commercial":{"annualCostUS":"$80,000/yr","genericStatus":"Generic — off-patent","currentRevenue":"$21.2B","peakSalesEstimate":"$21.2B"},"references":[{"id":1,"url":"https://clinicaltrials.gov/search?intr=ritlecitinib-20-mg","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ritlecitinib-20-mg","fields":["publications"],"source":"PubMed/NCBI"},{"id":3,"url":"https://www.ebi.ac.uk/chembl/","fields":["molecular"],"source":"ChEMBL (EMBL-EBI)"},{"id":4,"url":"https://www.ema.europa.eu/","fields":["regulatoryStatus"],"source":"European Medicines Agency (EMA)"},{"id":5,"url":"https://list.essentialmeds.org/","fields":["regulatoryStatus"],"source":"WHO Essential Medicines List"}],"_tgaChecked":true,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-19T23:56:55.367434+00:00","fieldsConflicting":2,"overallConfidence":0.8},"_whoChecked":true,"biosimilars":[],"competitors":[{"name":"Spironolactone","company":"Aldactone, CaroSpir","advantage":"Used to remove excess fluid (edema) from the body, lower blood pressure, or treat conditions such as heart failure, or high blood pressure."},{"name":"Minoxidil topical","company":"Rogaine, Rogaine Men's Extra Strength","advantage":"Used to treat alopecia, androgenetic alopecia, and promote hair growth."},{"name":"Litfulo","company":"N/A","advantage":"N/A"},{"name":"Triamcinolone","company":"Kenalog-10","advantage":"N/A"},{"name":"Kenalog-10","company":"N/A","advantage":"N/A"}],"genericName":"ritlecitinib-20-mg","indications":{"approved":[{"name":"Moderate to severe alopecia areata","regulator":"FDA"}],"offLabel":[],"pipeline":[]},"_mhraChecked":true,"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT05650333","phase":"PHASE1","title":"A Study to Learn About the Study Medicine (Called Ritlecitinib) For the Potential Treatment of Severe Alopecia Areata (AA) In Children 6 To Less Than 12 Years of Age","status":"COMPLETED","sponsor":"Pfizer","startDate":"2023-03-02","conditions":"Alopecia Areata","enrollment":15}],"_emaApprovals":[{"date":"","name":"Ritlecitinib 20 mg","status":"Authorised","regulator":"EMA"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"molecularData":{"oral":true,"chemblId":"CHEMBL5314649","moleculeType":"Small molecule","molecularWeight":"457.56"},"_patentsChecked":true,"_warningLetters":[{"date":"03/28/2023","subject":"11/07/2022\tTodos Medical Ltd aka Todos Medical USA Inc\tCenter for Food Safety and Applied Nutrition"},{"date":"03/27/2026","subject":"Feedback form"}],"crossReferences":{"chemblId":"CHEMBL5314649"},"formularyStatus":[],"_offLabelChecked":true,"developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Dermatology"],"biosimilarFilings":[],"recentPublications":[],"_drugWebsiteChecked":true,"_healthCanadaChecked":true,"companionDiagnostics":[],"_genericFilersChecked":true,"genericManufacturerList":[],"phase":"marketed","status":"active","companyName":"Pfizer","companyId":"pfizer","modality":"small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":3,"regulatoryByCountry":[{"country_code":"EU","regulator":"EMA","status":"pending","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"pricingByCountry":[{"country_code":"US","currency":"USD","price_amount":"80000.00","price_per":"year","price_type":"annual_list","annual_cost_usd":null,"reimbursement_status":null}],"trialStats":{"total":1,"withResults":1},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-19T23:56:55.367434+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}